Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NICE (UK National Institute for Clinical Excellence) sets ECT (electroconvulsive therapy) standards:

This article was originally published in Clinica

Executive Summary

The UK's National Institute for Clinical Excellence (NICE) has recommended that electroconvulsive therapy (ECT) be considered for use in certain circumstances by the NHS in England and Wales. ECT will be considered when seeking a rapid and short-term improvement of severe symptoms of severe depressive illness, catatonia and prolonged or severe manic episodes. The guidance has been issued following the recent dismissal of a challenge to its approval (see Clinica No 1053, p 6). In 1999, the NHS administered ECT around 20,000 times.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT062040

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel